Venture Capital

Connetic Venture Capital Access Fund

Formation2023

CategoryInterval Fund

SEC Filing ↗

Net Assets

$44.7M

NAV YoY

N/A

Portfolio Composition

Investment Type

Common Stock in Private Companies

2.40%

Preferred Stock in Private Companies

32.20%

Simple Agreement for Future Equity in Private Companies

29.70%

Convertible Note in Private Companies

23.70%

Exchange Traded Funds

9.30%

Common Stock in Public Companies

0.00%

Derivative in Public Companies

0.00%

Short-Term Investments

2.40%

Other assets in excess of liabilities

0.30%

Geography

North America

59.40%

Europe

4.80%

Global

27.00%

Other

8.80%

Strategy

Pre-Seed

28.13%

Seed

57.29%

Series A

9.38%

Public & Secondary Market

5.21%

Portfolio composition data sourced from regulatory filings.

Deeper Analysis

Institutional intelligence and portfolio transparency

Reported as of September 2025

Principal Portfolio Holdings

Holding	Value	Allocation
Cary Rx Inc. - Cary Rx Inc.2	$4.8M	10.67%
Get Bizzy, Inc. - Get Bizzy, Inc. (Seed)	$3.9M	8.71%
Cary Rx Inc.	$3.1M	7.03%
Proprietary Exposure	---	---
Proprietary Exposure	---	---

Showing 3 of 109 holdings. Pro access required for full portfolio disclosure.

Upgrade to Pro Analysis

Complete Intelligence Layer

Unlock deeper insights including Peer Benchmarking, Historical Performance Attribution, Fee Structure Analysis, and Liquidity Stress Models.

Contact for Firm-Wide Access

About This Fund

The Connetic Venture Capital Access Fund is a '40 Act registered closed-end investment company operating as an interval fund managed by Connetic RIA LLC. It focuses on equity securities of early-stage private venture capital investments, primarily targeting North American technology companies with additional exposure to consumer products and consumer discretionary sectors. The fund utilizes proprietary AI-driven screening technology called Wendal and offers quarterly repurchase opportunities at net asset value for liquidity.